Skip to contentA
Ardent Health, Inc.
A
ARDTArdent Health, Inc. Q1 2026 · 10-Q
Revenue$1.60B$1.60B+7.0% vs Q1 2025 Net Income$39.85M$39.85M−3.7% vs Q1 2025 EPS Diluted$0.28$0.28−3.4% vs Q1 2025 Operating Cash Flow-$60,222,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ardent Health, Inc. · CIK 1756655 · Engraved from SEC EDGAR
Net margin2.5%−0.3 pt vs Q1 2025
ended Mar 31, 2026 · filed May 6, 2026 · 36 d after period end